Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsIpcalaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Jyothy Labs, IPCA Labs, Hexaware Tech: Sharmila Joshi

      Sharmila Joshi, Market Expert recommends buying Hexaware Technologies for a target price of Rs 220 and IPCA Laboratories for a target price of Rs 696.

    • Bull's Eye: Buy DCB Bank, Berger Paints, TBZ, Texmaco Rail

      Dharmesh Kant of India Nivesh Securities recommends buying Texmaco Rail and Engineering with a target at Rs 130 and DCB Bank with a target at Rs 120.

    • Buy NMDC, M&M Fin, Union Bank, IPCA Labs: AK Prabharkar

      AK Prabharkar, Independent Advisor recommends buying IPCA Labs for a target price of Rs 714 and Union Bank for a target price of Rs 235.

    • Bull's Eye: Buy Tata Comm, NMDC, Union Bank, Texmaco Rail

      Pankaj Jain of Sunteck Wealthmax recommends buying Texmaco Rail and Engineering with a target price of Rs 131 and Tata Communications with a target price of Rs 479.

    • Stay invested in Ipca Labs: Mayuresh Joshi

      According to Mayuresh Joshi, VP- Institution at Angel Broking, one may hold Ipca Laboratories with a long term view.

    • Buy Ipca Laboratories, says Taher Badshah

      According to Taher Badshah, Fund Manager at Motilal Oswal Asset Management, one may buy Ipca Laboratories with a long term view.

    • Here are top 10 stocks to focus on November 12

      Here are top 10 stocks to focus on November 12 - Jindal Saw, TVS Motor, Prestige Estates, Shalimar Paints, Ipca Labs, Minda Industries, BILT, Bayer Crop, Hero Moto and Bajaj Auto.

    • Bullish on pharma; buy Lupin, Dr Reddys, Ipca: JM Financial

      For the largecap pharma companies the game has become completely US-cued. So, US will be the driver for Dr Reddys and Lupin, says Anmol Ganjoo.

    • Ipca Laboratories may touch Rs 800: Phani Sekhar

      Phani Sekhar, Fund Manager-PMS at Angel Broking feels that Ipca Laboratories may touch Rs 800.

    • Remain invested in Ipca Laboratories: Ashu Madan

      Ashu Madan of Religare Securities is of the view that one may remain invested in Ipca Laboratories.

    • Hold Ipca Laboratories, says Arvind Bothra

      Arvind Bothra, VP - Institutional Research at Religare Capital Markets is of the view that one may hold Ipca Laboratories.

    • Invest in Ipca Laboratories, says Kunj Bansal

      Kunj Bansal of Centrum Wealth Management advises investing in Ipca Laboratories.

    • Prefer Ipca, Unichem Labs, Indoco Remedies: Sandeep Shenoy

      Sandeep Shenoy of Anand Rathi Financial Services is of the view that one may prefer Ipca Laboratories, Unichem Laboratories and Indoco Remedies from the pharma space.

    • Buy Ipca Laboratories, Aurobindo: Kunj Bansal

      According to Kunj Bansal of Centrum Wealth Management, one may buy Ipca Laboratories and Aurobindo Pharma.

    • Buy IRB Infra, IOC; short LIC Housing: Rakesh Gandhi

      Independent Technical Analyst, Rakesh Gandhi is of the view that one may buy Ipca Laboratories for target of Rs 844 and sell LIC Housing Finance with a target of Rs 187.1.

    • Bull's Eye: Buy India Cements, IRB Infra; sell LIC Housing

      Pankaj Jain of Sunteck Wealthmax advises buying Marksans Pharma for a target price of Rs 18.85 and Aurobindo Pharma for a target price of Rs 468.

    • Buy Apollo Tyres, Tata Elxsi, Ipca Lab: Pankaj Jain

      Pankaj Jain of Sunteck Wealthmax suggests buying Glenmark Pharma for a target price of Rs 569 and Tata Elxsi for a target price of Rs 406.75.

    • Buy Glenmark, Ipca Lab, Godrej Consumer: Rakesh Gandhi

      Independent Technical Analyst, Rakesh Gandhi advises buying Godrej Consumer Products for a target price of Rs 735 and Glenmark Pharma for a target price of Rs 570.

    • Bull's Eye: Buy Ipca Labs, TVS Motor, Glenmark, Escorts

      Pankaj Jain of Sunteck Wealthmax advises buying Apollo Tyres for a target price of Rs 114.75 and Tata Elxsi for a target price of Rs 406.75.

    • Stay invested in Ipca Laboratories: Phani Sekhar

      Phani Sekhar of Angel Broking advises holding Ipca Laboratories.

    • Buy UPL, NIIT Technologies, AIA Engineering: Paras Bothra

      According to Paras Bothra of Ashika Stock Broking, one may buy Ipca Laboratories with a target of Rs 790 and NIIT Technologies with a target of Rs 415.

    • Bull's Eye: Buy Rel Comm, TVS Motor, UPL, SKS Microfinance

      Independent Advisor AK Prabharkar advises buying NIIT Technologies for a target price of Rs 430 and SKS Microfinance for a target price of Rs 200.

    • Prefer HCL Tech, TCS, Tata Steel, UPL, Dabur: Joshi

      Mayuresh Joshi of Angel Broking prefers HCL Technologies and Tata Consultancy Services (TCS) from the IT pack where the earnings growth both in dollar and rupee terms will be exceptional for these companies going forward.

    • Book partial profits in Aurobindo Pharma: Mayuresh Joshi

      Mayuresh Joshi of Angel Broking suggests partial profits booking in Aurobindo Pharma and prefers Ipca Laboratories and Cadila Healthcare for 15-20 percent return.

    • Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra

      Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top picks in the pharma space.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347